Real World Experience with Maribavir for the Treatment of Cytomegalovirus in Solid Organ Transplant Recipients

被引：0
|
作者：
Sabatino, D. [1 ]
Hedvat, J. [1 ]
Salerno, D. M. [1 ]
Pereira, M. [2 ]
Lange, N. W. [3 ]
机构：
[1] NewYork Presbyterian Hosp, New York, NY USA
[2] Columbia Univ, Irving Med Ctr, New York, NY USA
[3] NewYork Presbyterian Hosp, Pharm, New York, NY USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2023年 / 23卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
D128
引用
收藏
页码：S1117 / S1117
页数：1
相关论文
共 50 条
  • [1] Real world experience with Maribavir for the treatment of cytomegalovirus in solid organ transplant recipients
    Sabatino, David C.
    Hedvat, Jessica
    Salerno, David M.
    Pereira, Marcus R.
    Lange, Nicholas W.
    CLINICAL TRANSPLANTATION, 2023, 37 (04)
  • [2] Real-World Experience With Maribavir for Treatment of Cytomegalovirus Infection in High-Risk Solid Organ Transplant Recipients
    Ni, Bin
    Wolfe, Cameron R.
    Arif, Sana
    Carugati, Manuela
    Heldman, Madeleine R.
    Messina, Julia A.
    Miller, Rachel A.
    Saullo, Jennifer L.
    Baker, Arthur W.
    Maziarz, Eileen K.
    OPEN FORUM INFECTIOUS DISEASES, 2024, 11 (07):
  • [3] Real-World Comparison of Maribavir to Foscarnet for the Treatment of Cytomegalovirus in Solid Organ and Hematopoietic Stem Cell Transplant Recipients
    Ogawa, Lauren
    Morinishi, Chelsea
    Multani, Ashrit
    Gaynor, Pryce
    Beaird, Omer E.
    Pham, Christine
    Schaenman, Joanna M.
    VIRUSES-BASEL, 2024, 16 (12):
  • [4] Early Experience with Maribavir in Solid Organ Transplant Recipients
    Xhemali, X.
    Eckardt, J.
    Koval, C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S942 - S942
  • [5] Evaluating Real-World Experience With Maribavir for Treatment of Refractory/Resistant Cytomegalovirus in Renal Transplant Recipients
    Beechar, Vivek B.
    Phadke, Varun K.
    Pouch, Stephanie M.
    Mehta, Aneesh K.
    Karadkhele, Geeta
    Larsen, Christian P.
    Woodworth, Michael H.
    CLINICAL TRANSPLANTATION, 2024, 38 (10)
  • [6] Letermovir and Maribavir for the Treatment and Prevention of Cytomegalovirus Infection in Solid Organ and Stem Cell Transplant Recipients
    Imlay, Hannah N.
    Kaul, Daniel R.
    CLINICAL INFECTIOUS DISEASES, 2021, 73 (01) : 156 - 160
  • [7] Characterization of Maribavir for Management of Resistant or Refractory Cytomegalovirus in Solid Organ Transplant Recipients
    Sterling, S.
    Agegnehu, B.
    Yakubu, I.
    Winstead, R.
    Brown, A.
    Iaria, A.
    Gupta, G.
    Morales, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S1115 - S1115
  • [8] Single-Center Experience with Maribavir for the Treatment of CMV Infection in Solid Organ Transplant Recipients
    Ni, B.
    Wolfe, C.
    Arif, S.
    Carugati, M.
    Heldman, M.
    Messina, J.
    Miller, R.
    Saullo, J.
    Baker, A.
    Maziarz, E. K.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S1102 - S1102
  • [9] Current Perspectives on Letermovir and Maribavir for the Management of Cytomegalovirus Infection in Solid Organ Transplant Recipients
    Razonable, Raymund R.
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2024, 18 : 3987 - 4001
  • [10] Real-World Experience With Maribavir for Treatment of Refractory or Resistant Cytomegalovirus Infection in Hematopoietic Cell Transplant Recipients and Hematologic Malignancy Patients
    Daher, Marilyne
    Khawaja, Fareed
    Spallone, Amy
    Shigle, Terri L.
    Bhatti, Micah
    Vuong, Nancy N.
    Ariza-Heredia, Ella J.
    Mulanovich, Victor
    Champlin, Richard E.
    Chemaly, Roy F.
    TRANSPLANT INFECTIOUS DISEASE, 2025,
12345